Weight Management Innovation Tour

Participation on site is open to all visitors on a first-come, first-served basis, with a maximum of 30 participants allowed per tour.

In the span of two years, molecules like semaglutide have redrawn the competitive landscape of an already complex category, forcing ingredient suppliers, food manufacturers, and nutrition brands to rethink their entire positioning, their formulations, and their consumer targeting from the ground up. The market is responding. From a valuation of $21.6 billion in 2025 to over $29 billion by 2033, European weight management nutrition is growing steadily, but the real story is not the size. It's the shift in how consumers are now managing their weight, and what they expect food and nutrition to do for them in that journey.

GLP-1 companion products. Muscle preservation formulas. Protein and fibre maximisation. Satiety-focused reformulations. A new generation of functional foods built around the realities of medically-assisted weight loss.

Which product formats are emerging around GLP-1 users? What nutritional gaps are opening up, and who is already filling them? And beyond the drug adjacency, where does the broader weight management opportunity actually sit?

Join the tour and see the opportunities in this category.

Reference: https://www.grandviewresearch.com/horizon/outlook/weight-management-nutrition-market/europe